baber/WOPTO huggingface dataset:
Patent DK-2149296-T3 (DK)
Inventor: VAN LEEUWEN MARCEL
IPC: A01K1/00
Filed: 2009-07-20
Granted: 2011-11-21
Abstract: The invention relates to a method, a control system (30) and a shed (1) wherein the lighting is adjusted depending on the presence of an animal in a specific section of a shed. The shed is divided into a number of sections (20,14,14',3,7), for example a separation section (14). When no cows have access to the separation section and the section is therefore empty, the control system ensures that the lighting in the respective section is switched off. As the control system according to the invention controls both access to the section and lighting thereof, it is possible to dispense with movement sensors for controlling lighting in the respective sections.
Patent DK-2316466-T3 (DK)
Inventor: NAHORI MARIE-ANNE
IPC: A61P25/00
Filed: 2002-12-11
Granted: 2013-11-18
Abstract: Compositions comprising components prepared from Gram positive bacteria such as Gram positive facultative intracellular bacteria, for example myco-bacteria, including extended freeze-dried killed Gram positive bacteria, their method of preparation and their use in humans and animals, for the prevention and/or the treatment of disorders comprising an immune dysregulation such as cancer, autoimmune diseases, allergy and tuberculosis.
Patent DK-2159128-T3 (DK)
Inventor: MUELLER MATTHIAS DR
IPC: B61L15/00
Filed: 2009-08-11
Granted: 2011-10-24
Abstract: The multi-system configuration has a course-side legacy system (2) with a path pulse generator (6) for speed determination and a master system, particularly European train control system (1). The master system is connected with the path pulse generator by a coupling (9) and an interface module (10). The master system produces control signals (11) for activating or deactivating the path pulse generator and a cab signal.
Patent DK-2400474-T3 (DK)
Title: Arrangement and method for flight security and/or air traffic control of aircraft
Inventor: BLOMENHOFER HELMUT DR
IPC: H04B7/185
Filed: 2009-01-10
Granted: 2018-03-19
Abstract: The arrangement has receiving stations (20) staying in connection with a flight security and/or air-traffic control central station (11). A part of the receiving stations is designed as satellite i.e. low earth orbit (LEO) satellite, receiving stations, such that the receiving stations receive a 1090 megahertz broadcast signal (5) transmitted by a transmission station (3) designed as a mode S extended squitter. A part of data contained in the signal is transmitted via a radio transmission route (21) to a satellite ground control station (22) and to the central station or other organizations. An independent claim is also included for a method for flight security and/or air-traffic control of an aircraft.
Patent DK-2733493-T3 (DK)
Title: In-vitro method for prognosis of the course of a cancer and by the outcome of a patient and means for carrying out this method
Inventor: PAGES FRANCK
IPC: G01N33/574
Filed: 2006-09-28
Granted: 2016-09-19
Abstract: The present invention relates to the prognosis of the outcome of a cancer in a patient, which prognosis is based on the quantification of one or several biological markers that are indicative of the presence of, or alternatively the level of, the adaptive immune response of said patient against said cancer.
Patent DK-2955917-T3 (DK)
Inventor: LEE TAMMY
IPC: H04N19/46
Filed: 2011-08-17
Granted: 2018-08-06
Abstract: Provided is a video encoding method, in order to encode a current region of a video, performing transformation on the current region by using transformation units in a variable tree-structure which are determined from among transformation units that are hierarchically split from a base transformation unit with respect to the current region and which are generated based on a maximum split level of a transformation unit; and outputting encoded data of the current region, information about an encoding mode, and transformation-unit hierarchical-structure information comprising maximum size information and minimum size information of the transformation unit with respect to the video.
Patent DK-0403763-T3 (DK)
Inventor: SCHENKYR RAINER
IPC: H04L12/46
Filed: 1990-04-26
Granted: 1994-10-24
Abstract: In the method for networking computers and/or computer networks, the occurrence of an interruption in the network system is determined and a redundant connection, which is inactive during undisturbed operation, is activated as a function thereof. The determination of an interruption takes place by testing whether a data signal occurs within a predetermined time interval on both the terminals of a redundant connection device (40) which are connected to the networking system. Various criteria are provided in order to interrupt a closed connecting ring, produced by activation of the redundant connecting device (40), when the original disturbance in the network system has been removed. Network systems and a circuit arrangement for carrying out the method are specified.
Patent DK-0457834-T3 (DK)
Inventor: SILVESTRI LOUI J
IPC: A61K9/50
Filed: 1990-02-08
Granted: 1994-10-31
Abstract: A multiphasic sustained release injectable delivery system is provided, as well as a method for treating humans and other mammals with that multiphasic sustained release system. The multiphasic sustained release system comprises prolonged, controlled delivery of microencapsulated allergen extract comprising allergen extract encapsulated in microcapsules of bioerodible encapsulating polymer, which permits a subtained, multiphasic release of said allergen extract, including (i) a first portion of allergen extract that upon injection is capable of being released from said microcapsules of bioerodible encapsulating polymer in a manner whereby only a relatively small amount of said allergen extract is released during said first phase, whereby initial allergenicity is minimized due to said first portion producing a mild local reaction similar to that normally observed with low doses of conventional allergen administration; and (ii) secondary portions of allergen extract that provide a substantially higher level of allergen extract in doses which could provoke a serious reaction in the patient, but for the prior release of said first portion.
Patent DK-0498098-T3 (DK)
Inventor: IBBOTT JACK KENNETH
IPC: C02F5/00
Filed: 1991-04-30
Granted: 1995-03-13
Abstract: The present invention relates to a method and apparatus for treating electrically conductive fluid. In one embodiment, positive (1) and negative (2) electrodes of electrically conductive materials having different electrochemical potentials are spaced apart. At least one of the electrodes has a covering of electrically insulative material (3,4) extending substantially therearound. Thus, the only electroconductlve connection that develops an electrochemical potential between the electrodes is established by a capacitive effect through the fluid to be treated, which fluid is passed between the electrodes (1,2). In another embodiment of the present invention, first and second electrodes (6,7) of electrically conductive material are spaced from one another, and at least one of the electrodes is provided with a covering of electrically insulative material (8,9) extending substantially therearound. An external source of energy (12) is connected to the first and second electrodes. Accordingly, when a body of electrically conductive fluid to be treated is interposed between the electrodes, an electroconductive connection between the electrodes is established through the body of fluid by a capacitive effect and the fluid is ionized. In each case, by providing at least one of the electrodes (1,2; 6,7) with a covering of electrically insulative material (3,4; 8,9), current flow between the electrodes is inhibited which contributes to the efficiency of the apparatus in ionizing fluid, even fluid having a high degree of electroconductive capability. <IMAGE>
Patent DK-0463773-T3 (DK)
Inventor: NAMIWA KIMIYOSHI
IPC: C10M169/04
Filed: 1991-06-13
Granted: 1993-10-18
Abstract: The invention relates to a refrigerator oil lubricant composition characterised in that it comprises (a) a polyoxyalkylene glycol ether having the formula (I) R1O(AO)nR2   (I) wherein AO is one or more groups selected from the group consisting of <CHEM> -CH2CH2- and -CH2O- and, in the case of two or more groups, they may together form a block copolymer or a random copolymer; n = p + q + r in which p is the average number of the groups represented by <CHEM> q is the average number of the groups represented by -CH2CH2O-, r is the average number of the groups represented by -CH2O-, p is in the range of 1 to 80, q is in the range of 0 to 60, r is 0 or 1 and the relation 0 </= q/(p+q) </= 0.6 holds; and R1 and R2 are each a hydrogen atom or a hydrocarbon group having 1 to 8 carbon atoms provided that they should not be simultaneously hydrogen atoms, and having a kinematic viscosity at 40 DEG C in the range of 6 to 500 cSt; and (b) 0.01 to 25 parts by weight, based on 100 parts by weight of said polyoxyalkylene glycol ether, of a polyglycidyl ether compound prepared from a dihydric or trihydric alcohol.
Patent DK-0467583-T3 (DK)
Inventor: VIJEH NADER
IPC: H03K5/156
Filed: 1991-07-10
Granted: 1996-04-29
Abstract: A discrete repeater (50) having a predetermined number of ports (60,62,100) includes an expansion port (100) permitting connection of one or more of similar devices to produce a single repeater unit having an increased number of ports. The expansion port (100) includes two bidirectional channels, an output channel and two input channels. An arbiter function connects to each discrete repeater to assert appropriate signals to permit the discrete repeaters making up a repeater unit to exchange data and collision information. This exchange of data is used in a state machine of the discrete repeaters (50) to provide a repeater unit with distributed repeater and relay functions. <IMAGE>
Patent DK-0472706-T3 (DK)
Inventor: GIRARD MARC
IPC: A61K39/00
Filed: 1991-03-16
Granted: 1997-12-29
Abstract: This invention relates to monoclonal or polyclonal antibodies having neutralizing properties regarding the infection by a determined virus, obtained after administration to a host, in an amount sufficient to induce neutralizing antibodies, of a composition comprising as a combined preparation for simultaneous, separate or sequential administration:   (A) at least one envelope glycoprotein of said virus or a fragment of at least 50 aminoacids of the glycoprotein and, (B) at least one peptide derived from the aminoacid sequence of the envelope glycoprotein, and wherein the peptide comprises at least one virus-neutralization epitope.   The invention further relates to the use of these antibodies as serotherapeutic drug.
Patent DK-0513502-T3 (DK)
Inventor: SCHUBERT KLAUS
IPC: H02G3/04
Filed: 1992-03-25
Granted: 1994-01-03
Abstract: The invention relates to a mounting channel for electrical cables, lines and similar objects. This channel has an essentially U-shaped base shape and one or more cover elements for closing the retaining space on the front side. Latching openings for the engagement of attachment arms of a wall bracket are arranged on the rear-side outer wall of the U-shaped base shape. The invention is that the engagement opening (11) is extended with its side walls (111, 112) into the partial retaining space (21). The side wall (111) runs in a rounded area (1111) into the base wall (113) which connects the two side walls (111, 112). The engagement opening (12), which is physically separate from the engagement opening (11), is constructed as an insertion opening, which runs parallel to the rear-side outer wall (3), for the associated attachment part (43) of the wall bracket (4).
Patent DK-0546647-T3 (DK)
Inventor: STRELOW HORST
IPC: G06F11/267
Filed: 1992-10-07
Granted: 1997-09-22
Abstract: The computers (MC1, MC2) of the computer system are associated with common input assemblies (S1.1) for the input signals (E1, E2) to be processed. These input signals are offered in two channels. The input signals corresponding to one another are ANDed with signal protection outside the computers and pass in this form to common input assemblies (S1.1). The input assemblies can be checked for correct operation in familiar manner. The individual computer which is supplied with the ANDed input signals transmits these to the remaining computers (MC2) of the computer system. When the method according to the invention is used, the amount of input assemblies in 2V2 systems which can be checked for their operability is reduced to 50%, and to 66% in the 2V3 system, of the amount compared with a computer system in which this method is not used. <IMAGE>
Patent DK-0569411-T3 (DK)
Inventor: ROSINI SERGIO
IPC: C07F9/38
Filed: 1992-01-20
Granted: 1995-08-28
Abstract: PCT No. PCT/EP92/00102 Sec. 371 Date Jul. 26, 1993 Sec. 102(e) Date Jul. 26, 1993 PCT Filed Jan. 20, 1992 PCT Pub. No. WO92/13864 PCT Pub. Date Aug. 20, 1992.Compounds of formula (I)   <IMAGE>   in which A is (CH2)n in which n is 1-10, preferably 3 or 5, and R is the acyl group from a known anti-inflammatory agent, exhibit high anti-inflammatory activity. The mechanism of action is novel because they do not release the anti-inflammatory agent in the body but exhibit an activity superior to the activity of the known anti-inflammatory agent. The compounds are also active in combating bone calcium loss.
Patent DK-0554414-T3 (DK)
Inventor: CORTES VALDES ELENA
IPC: A61K39/00
Filed: 1992-03-26
Granted: 1998-09-07
Abstract: The invention relates to a method for producing a subunit vaccine against canine parvovirus (CPV) and other related viruses (FPLV and MEV). The method is comprised of a first step to obtain a recombinant protein VP2 of CPV using the replication of a recombinant baculovirus, wherein the gene corresponding to the VP2 had been previously introduced in cells of a permissive host. The protein VP2 obtained in this invention has the capacity of forming empty chimeric capsides with high immunogenicity so that they can be formulated into vaccines for protecting animals against infection caused by CPV, FPLV and MEV. Additionnaly they may be chemically or genetically engineered in order to incorporate epitopes corresponding to other viral proteins and they may be used in the formulation of polyvalent vaccines. The recombinant baculovirus AcMNPV.pCPVEx17 expresses the protein VP2 of the virus CPV in conditions which enable it to form pseudo-viral capsides and has been deposited at the ECACC. Said vaccine finds application in the veterinary field. <IMAGE>
Patent DK-0571041-T3 (DK)
Inventor: MESSINA GIUSEPPE
IPC: C07B61/00
Filed: 1993-05-18
Granted: 1997-07-07
Abstract: A continuous process for the production of oxamide is based on the catalytic oxidation of hydrogen cyanide with oxygen or air in a strong excess in a solution of copper nitrate in water-acetic acid. The process is carried out in a vertical tubular reactor, with continuous recycling of part of the suspension of oxamides from the bottom to the top of the reactor. <IMAGE>
Patent DK-0598690-T3 (DK)
Inventor: ALTHIN ANDERS
IPC: B01D65/00
Filed: 1993-11-11
Granted: 1999-04-26
Abstract: Semipermeable membranes are disclosed for purifying aqueous biological fluids. The membranes are particularly suitable for purifying extracorporeal blood via hemodialysis. The membranes, preferably configured as hollow fibers, are made from a hydrophilic polymeric material, preferably cellulose acetate. Features of the membranes include an ultrafiltration coefficient (KuF) of about 15 to about 55 mL/hr/mmHg/m<2> (thus termed "high-flux" type membranes), a urea mass transfer coefficient (KoV(urea)) of at least 38x10<-><3> cm/min, and a ratio of KoV(urea)/KuF of at least 2.5x10<-><3>. Hollow fibers of such membranes suitable for hemodialysis have a lumen diameter of about 175 to about 210  mu m and a wall thickness of about 10 to about 35  mu m. According to disclosed methods for making the membranes, a melt comprising about 32 to about 40% w/w cellulose acetate, about 5 to about 10% w/w glycerine, and about 50 to about 67% w/w polyethylene glycol is extruded to make hollow fibers; the fibers are cooled, cold-stretched, water-leached, and replasticized using a glycerine solution.
Patent DK-0613942-T3 (DK)
Inventor: SU DEAN T
IPC: A61K8/64
Filed: 1994-03-04
Granted: 1999-08-23
Abstract: 1. In accordance with the invention there is an aqueous composition comprising     a. about 5-10 wt% of <CHEM> wherein R is alkyl and/or alkenyl having an average of from about 8 to 18 carbon atoms, inclusive;     n is 1, 2 or 3;     o, p and q are the same or different and are 1, 2 or 3;     X is an alkali metal or amine cation;   b. about 1 to 8 wt% of    R<1>-(OCH2CH2)m-OSO3<->Y<+>    wherein R<1> is alkyl and/or alkenyl of about 8 to 18 carbon atoms, inclusive;     m is 0 or 1-10,     y is an alkali metal or amine cation;   c. about 0.5 to 5 wt% of a soap;   d. about 1 to 5 wt% of an acylated hydrolyzed protein salt wherein the acyl group is alkyl and/or alkenyl carboxy acyl having an average number of carbon atoms of about 8 to 20 carbon atoms, inclusive; and e. about 0.1 - 5 wt% of an acyl glutamate salt wherein the acyl group is alkyl and/or alkenyl carboxy acyl having an average number of carbon atoms of from about 8 to 20 carbon atoms, inclusive.
Patent DK-0610126-T3 (DK)
Inventor: MEDARD JOEL
IPC: H01Q9/04
Filed: 1994-01-31
Granted: 1998-12-14
Abstract: The microstrip antenna device comprises: a dielectric layer (CD), carrying, on one side, a conducting block (PC) of chosen form and, on the other, a conducting plane forming an earth plane (PM); and a feed circuit comprising at least one microstrip line (LM) connected to the conducting block (PC) and embedded in the dielectric layer (CD) in the same plane as the conducting block (PC). The thickness of the dielectric layer with respect to the microstrip line (EL) is greater than that with respect to the periphery of the said microstrip line (ML). <IMAGE>
Patent DK-0678025-T3 (DK)
Inventor: GIOVANELLA BEPPINO C
IPC: C07D491/22
Filed: 1994-01-14
Granted: 1998-10-07
Abstract: Use of a water-insoluble S-camptothecin with a closed lactone ring, which is e.g. 20(S)-camptothecin, 9-nitro-20(S)-camptothecin or 9 amino-20(S)-camptothecin in the manufacture of a medicament for the treatment of colon cancer. The medicament may be administered via an intramuscular, oral or transdermal route. Oral administration of 20(S)-camptothecin, 9-vitro-20(S)-camptothecin or 9-amino-20(S)-camptothecin may be used in a regimen of treating with the compound for 5 consecutive days and with 2 consecutive day intervals of no treatment.
Patent DK-0725918-T3 (DK)
Inventor: SCHULZ HARALD
IPC: F24J2/00
Filed: 1994-10-12
Granted: 1998-03-09
Abstract: The outer wall structure has an outer transparent heat-insulating layer (30) arranged between an outer transparent permeable shell (10) and an inner shell (20), next to the outer shell (10), as well as an inner heat-insulating layer (22) that is part of the inner shell (20). A radiation-permeable separating layer (21') that absorbs an alpha fraction of the solar radiation from the outer heat-insulating layer (30) is located between the outer heat-insulating layer (30) and the inner heat insulating layer (22). The heat transfer resistance Ra of outer shell (10) and outer heat-insulating layer (30) and their total energy transmittance g, as well as the absorbance alpha at the separating layer (21') and the heat transfer resistance Ri of the inner shell (20) with its inner heat-insulating layer (22) are adapted to each other so that at the highest expected insolation and highest outer temperature in summer the separating layer (21') reaches at the most a maximum temperature that can be supported by the materials in the wall structure without damage, whereas the maximum temperature reached at the wall inner surface is still felt as comfortable by persons inside the building.
Patent DK-0763032-T3 (DK)
Inventor: VERHOEVEN THOMAS R
IPC: A61K31/415
Filed: 1995-05-19
Granted: 2004-02-09
Abstract: A new process is described for the synthesis of the triazolyl tryptamine:   <IMAGE>   and related compounds. The process involves a palladium-catalyzed ring closure between a substituted ortho-iodoaniline and a protected 1-alkynol. The process is carded out at high temperature, e.g. 100 DEG  C., in a dry inert solvent, e.g., DMF and in the presence of a proton acceptor, e.g., Na2CO3 or a trialkylamine. The triazolyl tryptamine, as well as acid addition salts thereof, is a 5 HT1D receptor agonist having anti-migraine properties.
Patent DK-0792825-T3 (DK)
Inventor: ALTEN KURT
IPC: B65G69/28
Filed: 1996-12-30
Granted: 2002-09-23
Abstract: The bridge plate (1) has at its front end a slide carriage (3) with extension (4) for resting on the platform of a lorry etc. The extension or slide carriage supporting same acts through a ram (14) on one end of a rotatable shaft (21) in order to rotate same. The ram is movable against a resetting force and extends in the longitudinal direction of the bridge while the shaft has at its other end a swivel lever (23) which forms or operates the support element. The shaft is mounted vertical and the swivel lever is located at the lower end. The length of the shaft is such that the swivel lever serving as the support element can be moved sideways in and out underneath the adjoining edge of a side plate either side of the bridge plate.
Patent DK-0769558-T3 (DK)
Inventor: YU YEUNG S
IPC: C12Q1/54
Filed: 1996-10-16
Granted: 2003-07-21
Abstract: A reagent strip for measuring glucose concentration in whole blood has reduced interference of hematocrit with the glucose measurement. When a biological fluid contacts the strip, it causes, in a reagent impregnated in the strip, a color change that is a measure of the glucose concentration in the fluid. However, the color change is also affected by the red blood cell concentration (hematocrit), thereby reducing the accuracy of the glucose measurement. The hematocrit effect is reduced by adding to the reagent an acrylic acid polymer.
Patent DK-0870416-T3 (DK)
Inventor: BRIEM UWE
IPC: H04Q11/04
Filed: 1996-12-04
Granted: 2003-05-19
Abstract: In up-to-date ATM network systems, data in cells is transmitted by the "weighted fair queueing scheduling" process. To use connection sections in a particularly efficient manner, the cell streams are prioritized on the basis of said known process in that the weighting factors allocated to a first quantity of cell streams are selected in a very different manner to the weighting factors allocated to the remaining quantity of cell streams.
Patent DK-0839798-T3 (DK)
Inventor: KEMPF DALE J
IPC: C07K5/04
Filed: 1990-05-17
Granted: 2005-12-19
Abstract: A retroviral protease inhibiting compound of the formula  A - X - B or a pharmaceutically acceptable salt, prodrug or ester thereof, wherein X is a linking group;  A is     (1) substituted amino,   (2) substituted carbonyl,   (3) functionalized imino,   (4) functionalized alkyl,   (5) functionalized acyl,   (6) functionalized heterocyclic or   (7) functionalized (heterocyclic)alkyl; and  B is     (1) substituted carbonyl independently defined as herein,   (2) substituted amino independently defined as herein,   (3) functionalized imino independently defined as herein,   (4) functionalized alkyl independently defined as herein,   (5) functionalized acyl independently defined as herein,   (6) functionalized heterocyclic independently defined as herein or (7) functionalized (heterocyclic)alkyl independently defined as herein. o